Treatment of drug-susceptible and drug-resistant tuberculosis
Related Research units
Abstract
Recent advances have enabled the use of shorter TB treatment regimens. Key changes in the management of TB are: 1-month preventive treatment with rifapentine and isoniazid 4-month treatment for paucibacillary TB in children 4-month treatment for PTB in adults based on rifapentine and 6-month treatment for MDR/RR-TB with bedaquiline, pretomanid, linezolid and moxifloxacin (BPaLM). However, the history of TB drug resistance, and limited capacity worldwide for DST, are cause for caution.
Bibliographical data
| Original language | German |
|---|---|
| Title of host publication | The Challenge of Tuberculosis in the 21st Century |
| Editors | Alberto L. García-Basteiro, Füsun Öner Eyüboglu, Molebogeng X. Rangaka |
| REQUIRED books only: Number of pages | 22 |
| Place of Publication | Sheffield |
| Publisher | European Respiratory Society |
| Publication date | 01.09.2023 |
| Edition | 3 |
| Pages | 117-138 |
| ISBN (Print) | 978-1-84984-169-6 |
| ISBN (Electronic) | 978-1-84984-170-2 |
| DOIs | |
| Publication status | Published - 01.09.2023 |
